Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2026-01-06 @ 7:08 PM
Study NCT ID:
NCT01642004
Status:
COMPLETED
Last Update Posted:
2022-12-28
First Post:
2012-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2014-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-09
First Submit QC Date:
None
Study First Post Date:
2012-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-19
Results First Submit QC Date:
None
Results First Post Date:
2016-03-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-12-16
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-11-22
Last Update Post Date:
2022-12-28
Last Update Post Date Type:
ACTUAL